Pfizer Inc. buy Guggenheim
Start price
11.12.24
/
50%
€24.08
Target price
11.12.25
€31.40
Performance (%)
-5.88%
Price
27.11.25
€22.25
Summary
This prediction is currently active. With a performance of -5.88%, the BUY prediction for Pfizer Inc. by Guggenheim is down slightly. A total of €0.41 was paid as dividends for this prediction. This prediction currently runs until 11.12.25. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pfizer Inc. | 5.027% | 5.027% |
| iShares Core DAX® | 3.608% | -2.170% |
| iShares Nasdaq 100 | 4.362% | -1.854% |
| iShares Nikkei 225® | 3.371% | -2.409% |
| iShares S&P 500 | 3.596% | -0.427% |
Comments by Guggenheim for this prediction
In the thread Pfizer Inc. diskutieren
Pfizer Inc. (NYSE: PFE) had its price target lowered by analysts at Guggenheim from $35.00 to $33.00. They now have a "buy" rating on the stock.
Ratings data for PFE provided by MarketBeat